Literature DB >> 28289809

Imaging characteristics associated with clinical outcomes in posterior reversible encephalopathy syndrome.

Andrew D Schweitzer1, Neal S Parikh2,3, Gulce Askin4, Ajay Nemade5, John Lyo6, Sasan Karimi6, Anna Knobel6, Babak B Navi2,3, Robert J Young6, Ajay Gupta5,3.   

Abstract

PURPOSE: Posterior reversible encephalopathy syndrome (PRES) is a disorder of cerebrovascular autoregulation that can result in brain edema, hemorrhage, and infarction. We sought to investigate whether certain imaging characteristics in PRES are associated with clinically significant patient outcomes.
METHODS: We retrospectively reviewed all cases of PRES occurring between 2008 and 2014 at two major academic medical centers. Demographic, clinical, and radiographic data were collected. We analyzed imaging studies for vasogenic edema, hemorrhage, and diffusion restriction. We performed univariate analysis and stepwise logistic regression to assess the association between our radiologic findings of interest and clinical outcomes as defined by hospital discharge disposition and modified Rankin scale (mRS) at time of discharge.
RESULTS: We identified 99 cases of PRES in 96 patients. The median age was 55 years (IQR 30-65) and 74% were women. In 99 cases, 60% of patients had active cancer, 19% had history of bone marrow or organ transplantation, 14% had autoimmune disease, and 8% were peripartum. Imaging at clinical presentation showed extensive vasogenic edema in 39%, hemorrhage in 36%, hemorrhage with mass effect in 7%, and restricted diffusion in 16%. In our final logistic regression models, the presence of extensive vasogenic edema, hemorrhage with mass effect, or diffusion restriction was associated with worse clinical outcome as defined by both discharge disposition (OR = 4.3; 95% CI: 1.4-36.3; p = 0.047) and mRS (OR = 3.6; 95% CI: 1.2-10.7; p = 0.019).
CONCLUSIONS: Extensive vasogenic edema, hemorrhage, and restricted diffusion on initial imaging in PRES are associated with worse clinical outcomes.

Entities:  

Keywords:  Hemorrhage; Ischemia; MRI; PRES; Posterior reversible encephalopathy syndrome; Vasogenic edema

Mesh:

Year:  2017        PMID: 28289809      PMCID: PMC5565839          DOI: 10.1007/s00234-017-1815-1

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  39 in total

1.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

2.  Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings.

Authors:  Jennifer E Fugate; Daniel O Claassen; Harry J Cloft; David F Kallmes; Osman S Kozak; Alejandro A Rabinstein
Journal:  Mayo Clin Proc       Date:  2010-05       Impact factor: 7.616

3.  Predictors of poor outcome in patients with posterior reversible encephalopathy syndrome.

Authors:  Archana Hinduja; Kenneth Habetz; Sunil Raina; Raghu Ramakrishnaiah; Ryan T Fitzgerald
Journal:  Int J Neurosci       Date:  2016-02-29       Impact factor: 2.292

4.  The Clinical Outcome of Posterior Reversible Encephalopathy Syndrome.

Authors:  B Gao; A Lerner; M Law
Journal:  AJNR Am J Neuroradiol       Date:  2016-06-30       Impact factor: 3.825

5.  Detection of microhemorrhage in posterior reversible encephalopathy syndrome using susceptibility-weighted imaging.

Authors:  A M McKinney; B Sarikaya; C Gustafson; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-12       Impact factor: 3.825

6.  Blood pressure fluctuations in posterior reversible encephalopathy syndrome.

Authors:  Alejandro A Rabinstein; Jay Mandrekar; Ryan Merrell; Osman S Kozak; Olayemi Durosaro; Jennifer E Fugate
Journal:  J Stroke Cerebrovasc Dis       Date:  2011-05-04       Impact factor: 2.136

7.  Imaging pattern of intracranial hemorrhage in the setting of posterior reversible encephalopathy syndrome.

Authors:  Aseem Sharma; Ryan T Whitesell; Kelsey J Moran
Journal:  Neuroradiology       Date:  2009-12-03       Impact factor: 2.804

8.  Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features.

Authors:  H M Hefzy; W S Bartynski; J F Boardman; D Lacomis
Journal:  AJNR Am J Neuroradiol       Date:  2009-04-22       Impact factor: 3.825

9.  Posterior reversible encephalopathy syndrome in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome.

Authors:  S M Jung; S-J Moon; S-K Kwok; J H Ju; K-S Park; S-H Park; H-Y Kim
Journal:  Lupus       Date:  2013-07-11       Impact factor: 2.911

10.  Cerebral infarction in eclampsia.

Authors:  Gerda G Zeeman; James L Fleckenstein; Diane M Twickler; F Gary Cunningham
Journal:  Am J Obstet Gynecol       Date:  2004-03       Impact factor: 8.661

View more
  21 in total

1.  Central PRES (posterior reversible encephalopathy syndrome) in HELLP syndrome.

Authors:  Mihaela Ionela Sarbu; Nicolae Sarbu
Journal:  Intern Emerg Med       Date:  2018-12-05       Impact factor: 3.397

2.  Common infectious diseases of the central nervous system-clinical features and imaging characteristics.

Authors:  Shan Li; Ivy P Nguyen; Kyle Urbanczyk
Journal:  Quant Imaging Med Surg       Date:  2020-12

3.  Posterior reversible encephalopathy with brainstem involvement.

Authors:  Mustafa Resorlu; Ozan Karatag; Nilufer Aylanc; Muhsin Ozgun Ozturk; Canan Akgun Toprak
Journal:  Intern Emerg Med       Date:  2017-10-05       Impact factor: 3.397

Review 4.  Infectious and inflammatory diseases of the central nervous system-the spectrum of imaging findings and differential diagnosis.

Authors:  Joseph M Rozell; Edward Mtui; Yu-Ning Pan; Shan Li
Journal:  Emerg Radiol       Date:  2017-08-22

5.  Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome.

Authors:  Neal S Parikh; Andrew D Schweitzer; Robert J Young; Ashley E Giambrone; John Lyo; Sasan Karimi; Anna Knobel; Ajay Gupta; Babak B Navi
Journal:  J Neurol Sci       Date:  2017-06-29       Impact factor: 3.181

6.  Brain Imaging of Patients with COVID-19: Findings at an Academic Institution during the Height of the Outbreak in New York City.

Authors:  E Lin; J E Lantos; S B Strauss; C D Phillips; T R Campion; B B Navi; N S Parikh; A E Merkler; S Mir; C Zhang; H Kamel; M Cusick; P Goyal; A Gupta
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-20       Impact factor: 3.825

7.  Cerebrospinal Fluid in Posterior Reversible Encephalopathy Syndrome: Implications of Elevated Protein and Pleocytosis.

Authors:  Colin A Ellis; Andrew C McClelland; Suyash Mohan; Emory Kuo; Scott E Kasner; Cen Zhang; Pouya Khankhanian; Ramani Balu
Journal:  Neurohospitalist       Date:  2018-09-27

8.  Clinical Correlates of Periodic Discharges and Nonconvulsive Seizures in Posterior Reversible Encephalopathy Syndrome (PRES).

Authors:  Laure Bastide; Benjamin Legros; Nishi Rampal; Emily J Gilmore; Lawrence J Hirsch; Nicolas Gaspard
Journal:  Neurocrit Care       Date:  2018-12       Impact factor: 3.210

9.  Risk factors for poor outcome in posterior reversible encephalopathy syndrome: systematic review and meta-analysis.

Authors:  Zheng Chen; Gang Zhang; Alexander Lerner; An-Hui Wang; Bo Gao; Jie Liu
Journal:  Quant Imaging Med Surg       Date:  2018-05

10.  Extensive Brainstem Posterior Reversible Encephalopathy Syndrome in a Hemodialysis Non-Adherent Patient.

Authors:  Ya Haddy Sallah; Adeel S Zubair; Jeffrey J Dewey
Journal:  Cureus       Date:  2021-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.